Jiangsu Recbio Technology's (HKG:2179) board approved the proposed conversion of 141,953,490 unlisted shares into H shares, a Wednesday Hong Kong bourse filing said.
Conversion will take place after the company obtains all necessary approvals.
Following completion, the company will have a total of 458,092,179 H shares in issue, making up 94.85% of its total share capital.
The firm will apply to the Hong Kong Stock Exchange to list and deal in the converted H shares.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。